Ark Biotech develops an intelligent biomanufacturing platform designed to accelerate the commercialization of scientific breakthroughs in biotechnology. By incorporating advanced modeling and simulation techniques, Ark's platform optimizes bioprocessing, significantly reducing the time and cost associated with drug development and production. Their offerings include a virtual bioreactor, which allows for unlimited experimentation, and a digital twin that enhances process efficiency. Ark aims to improve human health, address climate change, and bolster national security by streamlining the transition of biotechnological innovations from the lab to the marketplace. The company values collaboration and innovation, bringing together experts in bioprocessing and simulation to foster a cutting-edge research environment dedicated to solving complex challenges in biomanufacturing.